Published in Int J Nephrol on September 11, 2013
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet (2004) 11.13
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Blood pressure and end-stage renal disease in men. N Engl J Med (1996) 5.68
Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation (1999) 5.04
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA (2001) 4.75
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA (2002) 2.98
Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension (2000) 2.35
The rationale and design of the AASK cohort study. J Am Soc Nephrol (2003) 2.34
The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology (1997) 2.31
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol (2003) 2.21
Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens (1987) 2.21
Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension (1998) 1.99
Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med (2000) 1.99
Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study. Circulation (2000) 1.89
Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am J Pathol (1991) 1.76
Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int (2001) 1.54
Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol (2000) 1.43
Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant (2002) 1.27
Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int (2002) 1.23
Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation (2001) 1.22
Aortic and large artery compliance in end-stage renal failure. Kidney Int (1990) 1.14
Arterial distensibility and left ventricular hypertrophy in patients with sustained essential hypertension. Am Heart J (1991) 1.12
Effects of local reduction in pressure on distensibility and composition of cerebral arterioles. Circ Res (1991) 1.10
Protection from atherosclerotic lesion formation by reduction of artery wall motion. J Vasc Surg (1987) 1.05
The importance of pulsatile components of hypertension in predicting carotid stenosis in older adults. J Hypertens (1997) 1.05
Systemic compliance: does it play a role in the genesis of essential hypertension? Cardiovasc Res (1984) 1.02
Determinants of isolated systolic hypertension in the elderly. J Hypertens Suppl (1992) 1.02
Reliability of stroke volume to pulse pressure ratio for estimating and detecting changes in arterial compliance. J Hypertens Suppl (1986) 0.95
Studies of the vessel wall properties in hemodialysis patients. Kidney Int (1994) 0.93
Hemodynamic correlates of arterial compliance. Cathet Cardiovasc Diagn (1986) 0.91
Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in high-risk hypertensive patients. Risk Intervention Study (RIS) Group. Arterioscler Thromb (1994) 0.89
Arterial wall properties in patients with renal failure. Am J Kidney Dis (2002) 0.88
Aortic distensibility is closely related to the progression of left ventricular hypertrophy in patients receiving hemodialysis. Angiology (2000) 0.79
Correlates of the estimated arterial compliance in the population of Tecumseh, Michigan. Blood Press (1992) 0.78
Hypertension and concomitant diseases: a guide for evidence-based therapy. J Natl Med Assoc (2004) 0.77
Gender differences in mediators of left ventricular hypertrophy in dialysis patients. Clin Nephrol (1998) 0.76
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29
In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73
Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect (2005) 10.66
Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79
Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet (2012) 6.69
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis (2012) 5.70
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45
Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol (2004) 5.29
Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2007) 5.26
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. Am J Kidney Dis (2011) 3.81
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol (2011) 3.52
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34
Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis (2010) 3.11
The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis (2005) 3.04
Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol (2008) 2.96
US Renal Data System 2010 Annual Data Report. Am J Kidney Dis (2011) 2.90
CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification? Hum Genet (2002) 2.90
Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86
Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am J Kidney Dis (2010) 2.83
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2005) 2.81
Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71
US Renal Data System 2013 Annual Data Report. Am J Kidney Dis (2014) 2.68
US Renal Data System 2012 Annual Data Report. Am J Kidney Dis (2013) 2.54
Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol (2006) 2.54
Racial differences in mortality among those with CKD. J Am Soc Nephrol (2008) 2.53
Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis (2012) 2.51
Related causal frameworks for surrogate outcomes. Biometrics (2009) 2.46
Cardiovascular events during differing hypertension therapies in patients with diabetes. J Am Coll Cardiol (2010) 2.43
Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2012) 2.42
High urine volume and low urine osmolality are risk factors for faster progression of renal disease. Am J Kidney Dis (2003) 2.41
The rationale and design of the AASK cohort study. J Am Soc Nephrol (2003) 2.34
Avosentan for overt diabetic nephropathy. J Am Soc Nephrol (2010) 2.32
Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med (2012) 2.24
Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension (2008) 2.24
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol (2003) 2.21
Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int (2004) 2.16
Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16
United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis (2009) 2.14
C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int (2005) 2.13
Effect of frequent hemodialysis on residual kidney function. Kidney Int (2013) 2.10
Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol (2005) 2.07
A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am J Public Health (2013) 2.04
Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis (2008) 2.01
Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment. Ann Pharmacother (2013) 1.99
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J (2006) 1.98
Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol (2005) 1.97
Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol (2013) 1.96
Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol (2007) 1.92
Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis. J Am Soc Nephrol (2010) 1.92
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol (2012) 1.90
Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int (2010) 1.88
The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD. Clin J Am Soc Nephrol (2013) 1.87
High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int (2011) 1.86
Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol (2003) 1.84
Performance of the Cockcroft-Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients. Am J Kidney Dis (2005) 1.83
Pyridorin in type 2 diabetic nephropathy. J Am Soc Nephrol (2011) 1.79
Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol (2009) 1.78
Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2002) 1.78
The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Arch Intern Med (2005) 1.76